441 related articles for article (PubMed ID: 28569732)
1. Inflammatory osteolysis: a conspiracy against bone.
Mbalaviele G; Novack DV; Schett G; Teitelbaum SL
J Clin Invest; 2017 Jun; 127(6):2030-2039. PubMed ID: 28569732
[TBL] [Abstract][Full Text] [Related]
2. Modulation of osteoclast function in bone by the immune system.
Quinn JM; Saleh H
Mol Cell Endocrinol; 2009 Oct; 310(1-2):40-51. PubMed ID: 19056462
[TBL] [Abstract][Full Text] [Related]
3. Microgravity induces pelvic bone loss through osteoclastic activity, osteocytic osteolysis, and osteoblastic cell cycle inhibition by CDKN1a/p21.
Blaber EA; Dvorochkin N; Lee C; Alwood JS; Yousuf R; Pianetta P; Globus RK; Burns BP; Almeida EA
PLoS One; 2013; 8(4):e61372. PubMed ID: 23637819
[TBL] [Abstract][Full Text] [Related]
4. Inflammasomes in Alveolar Bone Loss.
Li Y; Ling J; Jiang Q
Front Immunol; 2021; 12():691013. PubMed ID: 34177950
[TBL] [Abstract][Full Text] [Related]
5. [Osteocytic osteolysis : measurements of the volume of osteocytic lacunae].
Matsuo K; Nango N
Clin Calcium; 2012 May; 22(5):677-83. PubMed ID: 22549192
[TBL] [Abstract][Full Text] [Related]
6. The cellular basis of bone resorption.
Chambers TJ
Clin Orthop Relat Res; 1980 Sep; (151):283-93. PubMed ID: 7418318
[TBL] [Abstract][Full Text] [Related]
7. Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.
Zhu X; Gao J; Ng PY; Qin A; Steer JH; Pavlos NJ; Zheng MH; Dong Y; Cheng TS
J Bone Miner Res; 2016 Mar; 31(3):560-72. PubMed ID: 26363136
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages.
Shimizu S; Okuda N; Kato N; Rittling SR; Okawa A; Shinomiya K; Muneta T; Denhardt DT; Noda M; Tsuji K; Asou Y
Arthritis Rheum; 2010 May; 62(5):1329-37. PubMed ID: 20155835
[TBL] [Abstract][Full Text] [Related]
9. M-CSF mediates TNF-induced inflammatory osteolysis.
Kitaura H; Zhou P; Kim HJ; Novack DV; Ross FP; Teitelbaum SL
J Clin Invest; 2005 Dec; 115(12):3418-27. PubMed ID: 16294221
[TBL] [Abstract][Full Text] [Related]
10. CLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis.
Huang YL; Chen ST; Liu RS; Chen YH; Lin CY; Huang CH; Shu PY; Liao CL; Hsieh SL
J Mol Med (Berl); 2016 Sep; 94(9):1025-37. PubMed ID: 27033255
[TBL] [Abstract][Full Text] [Related]
11. Inflammasomes in Bone Diseases.
Mbalaviele G; Veis DJ
Exp Suppl; 2018; 108():269-279. PubMed ID: 30536175
[TBL] [Abstract][Full Text] [Related]
12. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-қB activation and titanium particle-induced osteolysis in a mouse model.
Huang J; Zhou L; Wu H; Pavlos N; Chim SM; Liu Q; Zhao J; Xue W; Tan RX; Ye J; Xu J; Ang ES; Feng H; Tickner J; Xu J; Ding Y
Mol Cell Endocrinol; 2015 Jan; 399():346-53. PubMed ID: 25448849
[TBL] [Abstract][Full Text] [Related]
14. Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.
Song F; Wei C; Zhou L; Qin A; Yang M; Tickner J; Huang Y; Zhao J; Xu J
J Cell Physiol; 2018 Feb; 233(2):1723-1735. PubMed ID: 28681916
[TBL] [Abstract][Full Text] [Related]
15. The cellular basis of bone turnover and bone loss: a rebuttal of the osteocytic resorption--bone flow theory.
Parfitt AM
Clin Orthop Relat Res; 1977; (127):236-47. PubMed ID: 912987
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 mediates osteolysis through inflammation-dependent and -independent mechanisms.
Qu C; Bonar SL; Hickman-Brecks CL; Abu-Amer S; McGeough MD; Peña CA; Broderick L; Yang C; Grimston SK; Kading J; Abu-Amer Y; Novack DV; Hoffman HM; Civitelli R; Mbalaviele G
FASEB J; 2015 Apr; 29(4):1269-79. PubMed ID: 25477279
[TBL] [Abstract][Full Text] [Related]
17. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
Sabokbar A; Kudo O; Athanasou NA
J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
[TBL] [Abstract][Full Text] [Related]
18. Osteoclasts; culprits in inflammatory osteolysis.
Teitelbaum SL
Arthritis Res Ther; 2006; 8(1):201. PubMed ID: 16356195
[TBL] [Abstract][Full Text] [Related]
19. RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis.
Ritchlin CT; Schwarz EM; O'Keefe RJ; Looney RJ
J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):276-84. PubMed ID: 15615495
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of osteoclast function and pathways.
Broadhead ML; Clark JC; Dass CR; Choong PF; Myers DE
Expert Opin Ther Targets; 2011 Feb; 15(2):169-81. PubMed ID: 21204734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
